Search Within

Pallawi Torka

Formats
  1. Meeting Abstract (43)
  2. Journal Article (12)
  3. Research Letter (3)
  4. Correspondence (2)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (30)
  2. Department of Medicine (30)
  3. Hematologic Malignancies, Division of (30)
  4. Lymphoma (30)
  5. Hematology-Oncology Fellows (28)
  6. Sloan Kettering Institute Postdocs (27)

More Groups

People
  1. Paul Hamlin (29)
  2. Anita Kumar (27)
  3. Paola Ghione (27)
  4. Andrew Zelenetz (26)
  5. Gilles Salles (26)
  6. Lorenzo Falchi (26)

More People

Years
  1. 2025 (8)
  2. 2024 (27)
  3. 2023 (27)
Publications
  1. Blood (39)
  2. Blood Cancer Journal (4)
  3. Hematological Oncology (4)
  4. Blood Advances (3)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. Journal of Geriatric Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (42)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (4)
  4. Wiley Blackwell (4)
  5. Biomed Central Ltd (3)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (62)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: A multicenter cohort study
    Journal Article

    Grover, N. S.; Annunzio, K.; Watkins, M.; Torka, P.; Karmali, R.; Anampa-Guzmán, A.; Oh, T. S.; Reves, H.; Tavakkoli, M.; Hansinger, E.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology
    Journal Article

    Gupta, M.; Akhtar, O. S.; Bahl, B.; Mier-Hicks, A.; Attwood, K.; Catalfamo, K.; Gyawali, B.; Torka, P.
    BMJ Oncology (2024)

    Fulltext@MSK | Save
  • Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report
    Editorial

    Abdallah, M.; Akhtar, O. S.; Major, A.; Mian, H.; Tsang, M.; Torka, P.
    Journal of Geriatric Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: A real-world analysis
    Research Letter

    Epperla, N.; Zhao, Q.; Moyo, T.; Watkins, M. P.; Tavakkoli, M.; Bello, C.; Torka, P.; Reddy, N.; Thomas, C.; Annunzio, K.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Impact of maintenance rituximab following first-line systemic therapy on outcomes in patients with marginal zone lymphoma: Real-world evidence from 10 US Centers
    Meeting Abstract

    Epperla, N.; Annunzio, K.; Shouse, G. P.; Grover, N. S.; Torka, P.; Watkins, M. P.; Anampa-Guzmán, A. C.; Oh, T. S.; Reves, H.; Tavakkoli, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - A US multisite study
    Meeting Abstract

    Epperla, N.; Annunzio, K.; Shouse, G. P.; Grover, N. S.; Torka, P.; Watkins, M. P.; Anampa-Guzmán, A. C.; Oh, T. S.; Reves, H.; Tavakkoli, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes in patients with classical Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: Real world analysis from 14 US academic centers
    Meeting Abstract

    Voorhees, T.; McLaughlin, E.; Torka, P.; Florindez, J. A.; Moyo, T. K.; Reves, H.; Sumransub, N.; Deshpande, S.; Rose, A.; Duarte, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Final results of a phase I/II trial of carfilzomib + R-CHOP for frontline treatment of patients with non-germinal center diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Hill, B. T.; Torka, P.; Hernandez-Ilizaliturri, F. J.; Dean, R. M.; Jagadeesh, D.; Karamlou, K.; Fu, C. L.; Winter, A.; Krauspe, E.; Zhou, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Antigen-specific t-cell repertoire responses following COVID-19 vaccination are intact in majority of patients with B-cell lymphoid malignancies on active therapy
    Meeting Abstract

    Goel, S.; Griffiths, E. A.; Segal, B.; Nemeth, M.; Cortese, M. J.; Hernandez-Ilizaliturri, F. J.; Banbury, B.; Schumacher, E.; Torka, P.; Ghione, P.
    Blood (2023)

    Fulltext@MSK | Save